Dr. Spyropoulos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
Rochester, NY 14642Phone+1 585-273-5573
Education & Training
University of New Mexico School of MedicineResidency, Internal Medicine, 1992 - 1995
Perelman School of Medicine at the University of PennsylvaniaClass of 1992
Certifications & Licensure
NY State Medical License 2011 - 2025
NM State Medical License 1992 - 2024- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2001
Clinical Trials
Publications & Presentations
PubMed
- 882 citationsDefinition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: co...Scott Kaatz, D Ahmad, A C Spyropoulos, Sam Schulman
Journal of Thrombosis and Haemostasis. 2015-11-01 - 167 citationsTreatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study.Charles W. Francis, Craig M. Kessler, Samuel Z. Goldhaber, Michael J. Kovacs, Manuel Monreal
Journal of Thrombosis and Haemostasis. 2015-06-01 - 31 citationsIncidence of venous thromboembolic events in COVID-19 patients after hospital discharge: A systematic review and meta-analysis.Marco Zuin, Matthias M Engelen, Stefano Barco, Alex C Spyropoulos, Thomas Vanassche
Thrombosis Research. 2022-01-01
Journal Articles
- Treatment of Venous Thromboembolism in Elite Athletes: A Suggested Approach to Individualized AnticoagulationAlex C Spyropoulos, Craig M Kessler, Bhavi Pandya, Seminars in Thrombosis and Hemostasis
Abstracts/Posters
- Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) StudyAlex Spyropoulos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Increased Risk of Death in Acutely Ill Medical Patients with Asymptomatic Proximal Deep Vein Thrombosis or Symptomatic Venous Thromboembolism: Insights from the Magell...Alex C. Spyropoulo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Rivaroxaban and Extended Thromboprophylaxis in Acutely Ill Medical Patients with History of Cancer: Insights from the Magellan and Mariner Studies61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan Trial61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan Trial61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Join now to see all
Press Mentions
Feinstein Institutes Research Suggests New Management Protocols for Patients Taking Oral AnticoagulantsSeptember 11th, 2024- When to Stop DOAC Before Urologic SurgeryAugust 26th, 2024
- COVID-19 Patients with Cardiovascular Disease More Likely to Develop Blood Clots Post-Hospital Discharge, Feinstein Institutes StudyMay 23rd, 2023
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
